These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 11333996)

  • 1. Meningococcal disease.
    Rosenstein NE; Perkins BA; Stephens DS; Popovic T; Hughes JM
    N Engl J Med; 2001 May; 344(18):1378-88. PubMed ID: 11333996
    [No Abstract]   [Full Text] [Related]  

  • 2. Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex.
    Popovic T; Sacchi CT; Reeves MW; Whitney AM; Mayer LW; Noble CA; Ajello GW; Mostashari F; Bendana N; Lingappa J; Hajjeh R; Rosenstein NE
    Emerg Infect Dis; 2000; 6(4):428-9. PubMed ID: 10905984
    [No Abstract]   [Full Text] [Related]  

  • 3. Meningococcal disease and prevention at the Hajj.
    Borrow R
    Travel Med Infect Dis; 2009 Jul; 7(4):219-25. PubMed ID: 19717104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and epidemiological implications of meningococcal disease.
    Meredith ; Galwankar S
    J Assoc Physicians India; 2005 Jul; 53():628-33. PubMed ID: 16190134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical practice. Prevention of meningococcal disease.
    Gardner P
    N Engl J Med; 2006 Oct; 355(14):1466-73. PubMed ID: 17021322
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidemiology and meningococcal serogroup distribution in the United States.
    Hershey JH; Hitchcock W
    Clin Pediatr (Phila); 2010 Jun; 49(6):519-24. PubMed ID: 20507868
    [No Abstract]   [Full Text] [Related]  

  • 7. Absence of Neisseria meningitidis from throat swabs of Kuwaiti pilgrims after returning from the Hajj.
    Husain EH; Dashti AA; Electricwala QY; Abdulsamad AM; Al-Sayegh S
    Med Princ Pract; 2010; 19(4):321-3. PubMed ID: 20516711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningococcal control in the United States and Africa.
    Plotkin SA; Kaplan SL
    J Infect Dis; 2006 Mar; 193(6):754-5. PubMed ID: 16479506
    [No Abstract]   [Full Text] [Related]  

  • 9. Advances in the development of vaccines against Neisseria meningitidis.
    Tan LK; Carlone GM; Borrow R
    N Engl J Med; 2010 Apr; 362(16):1511-20. PubMed ID: 20410516
    [No Abstract]   [Full Text] [Related]  

  • 10. The epidemiology and control of invasive meningococcal disease.
    Diaz PS
    Pediatr Infect Dis J; 1999 Jul; 18(7):633-4. PubMed ID: 10440442
    [No Abstract]   [Full Text] [Related]  

  • 11. The risk of meningococcal disease in travelers and current recommendations for prevention.
    Steffen R
    J Travel Med; 2010; 17 Suppl():9-17. PubMed ID: 20849428
    [No Abstract]   [Full Text] [Related]  

  • 12. [Advances in vaccines and invasive disease in children].
    Moraga Llop FA
    Rev Esp Quimioter; 2001 Dec; 14(4):319-30. PubMed ID: 11856977
    [No Abstract]   [Full Text] [Related]  

  • 13. Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964-1998.
    Brundage JF; Ryan MA; Feighner BH; Erdtmann FJ
    Clin Infect Dis; 2002 Dec; 35(11):1376-81. PubMed ID: 12439801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass antibiotic treatment to stop an outbreak of meningococcal disease: a molecular analysis.
    Katz LH; Zelazny A; Scharf S; Hourvitz A; Asor N; Arbeli Y; Yust-Katz S; Smollan-Fredman G; Gdalevich M
    Clin Microbiol Infect; 2007 Sep; 13(9):943-6. PubMed ID: 17635531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outbreaks of group B meningococcal disease--Florida, 1995 and 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Oct; 47(39):833-7. PubMed ID: 9780239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Continuing increase in the incidence of serogroup C meningococcal disease. Should we decide to vaccinate?].
    Soult Rubio JA; Muñoz Sáez M; López Castilla JD; Rodríguez Becerra A; Romero Parreño A; Tovaruela Santos A
    An Esp Pediatr; 2000 Jul; 53(1):75-6. PubMed ID: 11203416
    [No Abstract]   [Full Text] [Related]  

  • 18. 2010 FIFA world cup South Africa: travel health issues and new options for protection against meningococcal disease.
    Zuckerman JN; Bröker M; Worth C
    Travel Med Infect Dis; 2010 Mar; 8(2):68-73. PubMed ID: 20478511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing meningococcal infection in college students.
    Harrison LH
    Clin Infect Dis; 2000 Apr; 30(4):648-51. PubMed ID: 10770724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serogroup B meningococcal disease: new outbreaks, new strategies.
    Wenger JD
    JAMA; 1999 Apr; 281(16):1541-3. PubMed ID: 10227326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 36.